Fat Loss (54 Offers)

CLASSIFICATION: BETA-2 AGONIST (FAT BURNER)
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS × 40 MCG
ACTIVE HALF-LIFE: 36–48 HOURS
DOSAGE: MEN 120–140 MCG/DAY, WOMEN 80–100 MCG/DAY
ACNE: NO
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NONE
AROMATIZATION: NONE
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
LABORATORY TESTED: VIEW LAB RESULTS

CLASSIFICATION: BETA-2 AGONIST, BRONCHODILATOR
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS x 40 MCG
ACTIVE HALF-LIFE: ~36 HOURS
DOSAGE: MEN 20–120 MCG/DAY
ACNE: NO
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: AXIOLABS
LABORATORY TESTED: VIEW LAB RESULTS

CLASSIFICATION: MULTI-AGONIST PEPTIDE (GLP-1, GIP, GLUCAGON)
ACTIVE SUBSTANCE: RETATRUTIDE
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: ~ 6–7 DAYS
DOSAGE: 0.5–12 MG WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS

CLASSIFICATION: NOOTROPIC & ANXIOLYTIC PEPTIDE
ACTIVE SUBSTANCE: SELANK
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: ~ 3–10 HOURS
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS

CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROXIMATELY 7 DAYS
DOSAGE: 0.25–2.4 MG WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS

CLASSIFICATION: BETA-2 ADRENERGIC AGONIST
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS (40 MCG/TABLET)
ACTIVE HALF-LIFE: ~ 36 HOURS
DOSAGE: 20–140 MCG DAILY
ACNE: NONE
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NONE
AROMATIZATION: NONE
MANUFACTURER: STEALTH LABS USA
SHIPPED WITHOUT LABEL!
LABORATORY TESTED: VIEW LAB RESULTS

CLASSIFICATION: THYROID HORMONE (T3 ANALOG)
ACTIVE SUBSTANCE: LIOTHYRONINE SODIUM
FORM: 100 TABLETS (50 MCG/TABLET)
ACTIVE HALF-LIFE: ~ 2.5 DAYS
DOSAGE: 12.5–75 MCG DAILY
ACNE: NONE
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): POSSIBLE AT HIGH DOSES
HEPATOTOXICITY: NONE
AROMATIZATION: NONE
MANUFACTURER: STEALTH LABS USA
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!

CLASSIFICATION: THYROID HORMONE COMBINATION (T4 + T3)
ACTIVE SUBSTANCES:
 - LEVOTHYROXINE SODIUM 50 MCG
 - LIOTHYRONINE SODIUM 12.5 MCG
FORM: 100 TABLETS x 62.5 MCG
ACTIVE HALF-LIFE: T4 ~7 DAYS; T3 ~1 DAY
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM

CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 100 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM

CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 25 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 25–50 MCG ONCE DAILY
ACNE: NOT TYPICAL
WATER RETENTION: ONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM

CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 50 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 25–50 MCG ONCE DAILY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM

CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 75 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM

CLASSIFICATION: THYROID HORMONE (T3)
ACTIVE SUBSTANCE: LIOTHYRONINE SODIUM
FORM: 100 TABLETS x 25 MCG
ACTIVE HALF-LIFE: ~1 DAY (RANGE ~1–2.5 DAYS)
DOSAGE: MEN 25-75 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM

CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 125 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM

CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 150 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM

CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 175 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM